跳至主要内容
临床试验/ACTRN12622000313730
ACTRN12622000313730已完成3 期

Comparative Efficacy of Intravitreal Bevacizumab and Topical Diclofenac Combined Therapy, Intravitreal Ketorolac, and Intravitreal Bevacizumab on Diabetic Macular Edema

Supanji Haryanto0 个研究点目标入组 82 人开始时间: 2022年2月21日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients diagnosed with diabetic macular edema in type 2 diabetes mellitus, over 18 years of age at the time of intravitreal injection and never received anti-VEGF intravitreal injection therapy nor retinal laser therapy.

排除标准

  • Patients who have significant media opacities that could preclude macular ocular coherence tomography (OCT) examination, failed to receive intravitreal injection of Bevacizumab for any reason, underwent intraocular surgery during the study period, were having infection / inflammation in the anterior segment and those who were on systemic or topical corticosteroid / Non Steroid Anti Inflammation Drugs (NSAID) therapy.

研究者

发起方
Supanji Haryanto

相似试验

Comparative Efficacy of Intravitreal Bevacizumab and... | 临床试验